C.J. Gelatine Products Ltd is engaged in the business of manufacturing of Gelatine and related by-products like Di-Calcium Phosphate, Ossein, etc.Product Overview: Gelatin is the main ingredient in empty capsules and soft-gel capsules. As a rich source of protein, Gelatin finds application in numerous end use sectors including pharma, food...
C.J. Gelatine Products has received a confirmation from its Registrar and Share Transfer Agent for the quarter ended June 30, 2025. This certificate verifies that all shares submitted for conversion from physical to electronic form during the period were correctly processed, with accepted or rejected transfers communicated to depositories. It...
Barclays Investments & Loans (India) Private Limited has announced a board meeting on May 30, 2025, to consider the financial results for the quarter and half-year. The company reported total revenue from operations of ₹1,056.02 million for the quarter ended March 31, 2025, up from ₹859.88 million in the same...
CJ Gelatine Products has announced a board meeting that approved the appointment of M/s Prem Chand Jain & Co., Chartered Accountants, as the company’s Internal Auditor for FY 2025-26. The firm, established in 1966, offers a broad range of services including audit, tax consultancy, and management advisory. This change aims...
CJ Gelatine Products Limited has provided a certificate from M.M. Chawla & Associates concerning compliance with securities regulations for the financial year ended March 31, 2025. This documentation supports the company's adherence to mandatory listing obligations, showcasing its commitment to regulatory compliance. Such transparency is vital for maintaining stakeholder confidence...
CJ Gelatine Products has submitted a Compliance Certificate under Regulation 7(3) of the SEBI Listing Obligations & Disclosure Requirements for the financial year ending March 31, 2025. This certificate, signed by both the Company's Compliance Officer and the Authorized Representative of its Share Transfer Agent, confirms adherence to regulatory requirements....
